The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A first-in-human phase I study of MORAb-004 (M4), a humanized monoclonal antibody recognizing endosialin (TEM-1), in patients with solid tumors.
Luis A. Diaz
Honoraria - Morphotek
Nilofer Saba Azad
No relevant relationships to disclose
Mrinal M. Gounder
No relevant relationships to disclose
Christina Marie Coughlin
Employment or Leadership Position - Morphotek
Jean Fishel
Employment or Leadership Position - Morphotek
Daniel O'Shannessy
Employment or Leadership Position - Morphotek
Luigi Grasso
Employment or Leadership Position - Morphotek
Jason Wustner
Employment or Leadership Position - Morphotek
Jagadeesh Aluri
Employment or Leadership Position - Morphotek
Jeff Parno
No relevant relationships to disclose
Richard D. Carvajal
No relevant relationships to disclose